Taper ii.Medwatch sent to the fda on 17/jul/2018.Device evaluation summary: the device was returned to apollo for analysis, and visual examination confirmed the connector type as taper ii.Needle marks were noted on the port septum and scratches were observed on the port housing.The band ring and shell were noted to be separated near the band buckle.An air leak test was performed and the band was noted to be leaking from the shell where the band had been separated near the buckle.A fill inspection test was performed and no blockage was observed.Under microscopic analysis, both ends of the separation of the band ring and shell, located approximately 2.85 inches from the band belt, were noted to have striated edges, consistent with damage from a surgical end cut to remove the device.Both ends of the partial separation of the band buckle and both ends of the band tubing were noted to have striated edges, consistent with damage from a surgical tool.Material degradation was noted to be covering approximately 70% of the outer surface of the band ring.Device labeling addresses the reported event as follows: adverse events: it is important to discuss all possible complications and adverse events with your patient.Complications which may result from the use of this product include the risks associated with the medications and methods utilized in the surgical procedure, the risks associated with any surgical procedure and the patient's degree of intolerance to any foreign object implanted in the body.Ulceration, gastritis, gastroesophageal reflux, heartburn, gas bloat, dysphagia, dehydration, constipation, and weight regain have been reported after gastric restriction procedures.Other adverse events considered related to the lap-band system that occurred in fewer than 1% of subjects included: esophagitis, gastritis, hiatal hernia, pancreatitis, abdominal pain, hernia, incisional infection, infection, redundant skin, dehydration, gi perforation, diarrhea, abnormal stools, constipation, flatulence, dyspepsia, eructation, cardiospasm, hematemesis, asthenia, fever, chest pain, incision pain, contact dermatitis, abnormal healing, edema, paresthesia, dysmenorrhea, hypochromic anemia, band leak, cholecystitis, esophageal dysmotility, esophageal ulcer, esophagitis, port displacement, port site pain, spleen injury and wound infection.Warnings: patients should be advised that the lap-band ap system is a long-term implant.Explant (removal) and replacement surgery may be indicated at any time.Medical management of adverse reactions may include explantation.Revision surgery for explantation and replacement may also be indicated to achieve patient satisfaction.
|